Longitudinal trends in dementia prevalence among individuals with type 2 diabetes in Taiwan (2009-2022)
- PMID: 40317911
- PMCID: PMC12209517
- DOI: 10.1111/jdi.70060
Longitudinal trends in dementia prevalence among individuals with type 2 diabetes in Taiwan (2009-2022)
Abstract
Objective: This study examined the population-based epidemiological prevalence of early- and late-onset dementia in individuals with type 2 diabetes mellitus (T2DM) compared with the general population in Taiwan from 2009 to 2022.
Methods: A 14-year nationwide population-based epidemiology study from 2009 to 2022 in Taiwan using the Taiwan National Health Insurance Research Database was conducted to examine the crude and age-standardized dementia prevalence in individuals aged <65 and ≥65. Multivariable logistic regression was used to assess factors associated with dementia prevalence in the T2DM population.
Results: Among individuals aged ≥65 with T2DM, age-standardized dementia prevalence increased from 5.83 per 100 in 2009 to 7.11 per 100 in 2022, while the crude prevalence ratio compared to the general population ranged from 1.19 to 1.08. In the 40-64 age group, standardized dementia prevalence ranged from 0.58 to 0.43 per 100, with crude ratios ranging from 1.76 to 1.41. Our study found a higher risk of dementia prevalence among individuals aged 65 years and older, particularly among those with T2DM. Although the overall prevalence of dementia in the 40-64 age group was lower compared to older adults, individuals in this younger group with T2DM exhibited a significantly higher risk of developing dementia. Given these findings, public policy should prioritize early preventive strategies for individuals with T2DM to monitor and mitigate dementia progression in patients with T2DM.
Keywords: Dementia; Prevalence trend; Type 2 diabetes mellitus.
© 2025 The Author(s). Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Approval of the research protocol: This study followed the Helsinki Declaration of the World Medical Association and was approved by the Institutional Review Board of Kaohsiung Medical University (KMUHIRB‐SV(I)20200016).
Informed Consent: N/A.
Approval date of Registry and the Registration No. of the study/trial: N/A.
Animal Studies: N/A.
Figures


Similar articles
-
Sodium-glucose cotransporter 2 inhibitors and inverse risk of new-onset atopic dermatitis in a cohort with diabetes: a nationwide active-comparator study.Br J Dermatol. 2025 Jun 20;193(1):74-84. doi: 10.1093/bjd/ljaf086. Br J Dermatol. 2025. PMID: 40037684
-
Delirium as a Precursor to Dementia in Elderly Type 2 Diabetes Mellitus Patients.J Clin Psychiatry. 2025 May 19;86(3):25m15798. doi: 10.4088/JCP.25m15798. J Clin Psychiatry. 2025. PMID: 40767775
-
Disparities in the Prevalence of Urinary Diseases Among Prisoners in Taiwan: Population-Based Cross-Sectional Study.JMIR Public Health Surveill. 2024 Dec 24;10:e60136. doi: 10.2196/60136. JMIR Public Health Surveill. 2024. PMID: 39727265 Free PMC article.
-
Systematic review on urine albumin testing for early detection of diabetic complications.Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300. Health Technol Assess. 2005. PMID: 16095545
-
Prevalence and odds of anxiety and depression in cutaneous malignant melanoma: a proportional meta-analysis and regression.Br J Dermatol. 2024 Jun 20;191(1):24-35. doi: 10.1093/bjd/ljae011. Br J Dermatol. 2024. PMID: 38197404
References
-
- WHO . Global status report on the public health response to dementia. Available from: https://wwwwhoint/publications/i/item/9789240033245 Accessed March 31, 20252021.
-
- WHO . Aging and health. Available from: https://wwwwhoint/news‐room/fact‐sheets/detail/ageing‐and‐health Accessed March 31, 20252022.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical